Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1: genes and variants
Explore variant evidence for Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 across 2 analyzed proteins (TERT, RPA1). Linked ClinVar records include 15 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
TERT: Telomerase reverse transcriptase
It extends telomeric DNA using an internal RNA template and helps counter progressive chromosome-end shortening in stem and proliferative cells. Loss-of-function variants cause telomere-biology disorders, while promoter activation and increased activity support unlimited proliferation in many cancers.
13 ClinVar pathogenic / likely pathogenic and 30 uncertain variants in TERT have source records linked to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1. Association strength is not clinical gene validity.
RPA1: Replication protein A 70 kDa DNA-binding subunit
It binds single-stranded DNA during replication, recombination, and repair, protecting exposed DNA and coordinating checkpoint and repair proteins. Rare pathogenic variants can cause telomere and genome-maintenance disorders, while somatic dysregulation contributes to replication-stress tolerance in cancer.
2 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in RPA1 have source records linked to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SCN2A.
ClinVar pathogenic and likely pathogenic variants linked to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TERT A716V | 716 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A716T | 716 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT R865H | 865 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT R631Q | 631 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A880T | 880 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT T567M | 567 | Pathogenic / likely pathogenic (★★) | |
| TERT V867M | 867 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A1009V | 1009 | CTE | Pathogenic / likely pathogenic (★★) |
| TERT H534R | 534 | RNA-interacting domain 2 | Pathogenic / likely pathogenic (★) |
| TERT F115L | 115 | GQ motif | Pathogenic / likely pathogenic (★) |
| TERT L841F | 841 | Reverse transcriptase | Pathogenic / likely pathogenic (★) |
| TERT L55Q | 55 | RNA-interacting domain 1 | Pathogenic / likely pathogenic |
| RPA1 E240K | 240 | OB | Pathogenic / likely pathogenic |
| RPA1 V227A | 227 | OB | Pathogenic / likely pathogenic |
| TERT V791I | 791 | Reverse transcriptase | Pathogenic / likely pathogenic |
Which prediction tools work for Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 91 out of 100
- REVEL: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 85 out of 100
- CATVariant: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 77 out of 100
- phyloP: 71 out of 100
- MetaSVM: 68 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 67 out of 100
- MetaLR: 66 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 58 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Dyskeratosis congenita also has ClinVar records linked to TERT variants; they fall mostly in different places as the Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 variants (23 pathogenic / likely pathogenic).
- Idiopathic pulmonary fibrosis also has ClinVar records linked to TERT variants; they fall mostly in different places as the Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 variants (13 pathogenic / likely pathogenic).
Diseases related to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
- Acute myeloid leukemia, also linked to TERT
- Dyskeratosis congenita, also linked to TERT
- Urinary bladder cancer, also linked to TERT
- Familial melanoma, also linked to TERT
- Idiopathic pulmonary fibrosis, also linked to TERT
- Melanoma, cutaneous malignant, also linked to TERT
- Lung adenocarcinoma, also linked to TERT
- Hepatocellular carcinoma, also linked to TERT
- Prostate cancer, also linked to TERT
- Lung carcinoma, also linked to TERT
- Interstitial lung disease, also linked to TERT
Frequently asked questions
Which genes have records linked to Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1?
This view contains 2 analyzed proteins: TERT, RPA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 15 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 55 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center